These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 9641714)
1. Treatment of the acute crisis in maple syrup urine disease. Nyhan WL; Rice-Kelts M; Klein J; Barshop BA Arch Pediatr Adolesc Med; 1998 Jun; 152(6):593-8. PubMed ID: 9641714 [TBL] [Abstract][Full Text] [Related]
2. Amino acid clearance during acute metabolic decompensation in maple syrup urine disease treated with continuous venovenous hemodialysis with filtration. Hmiel SP; Martin RA; Landt M; Levy FH; Grange DK Pediatr Crit Care Med; 2004 May; 5(3):278-81. PubMed ID: 15115568 [TBL] [Abstract][Full Text] [Related]
3. Diagnosis and treatment of maple syrup disease: a study of 36 patients. Morton DH; Strauss KA; Robinson DL; Puffenberger EG; Kelley RI Pediatrics; 2002 Jun; 109(6):999-1008. PubMed ID: 12042535 [TBL] [Abstract][Full Text] [Related]
4. Intravenous administration of a branched-chain amino-acid-free solution in children and adults with acute decompensation of maple syrup urine disease: a prospective multicentre observational study. Alili JM; Berleur MP; Husson MC; Mention K; Schiff M; Arnoux JB; Brassier A; Guemman AS; Grisel C; Dubois S; Abi-Wardé MT; Broissand C; Servais A; Dao M; de Lonlay P Orphanet J Rare Dis; 2022 May; 17(1):202. PubMed ID: 35578286 [TBL] [Abstract][Full Text] [Related]
5. Plasma amino acid analyses in two cases of maple syrup urine disease. Surarit R; Srisomsap C; Wasant P; Svasti J; Suthatvoravut U; Chokchaichamnankit D; Liammongkolkul S Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():138-9. PubMed ID: 11400750 [TBL] [Abstract][Full Text] [Related]
6. The need of essential amino acids in children. An evaluation based on the intake of phenylalanine, tyrosine, leucine, isoleucine, and valine in children with phenylketonuria, tyrosine amino transferase defect, and maple syrup urine disease. Kindt E; Halvorsen S Am J Clin Nutr; 1980 Feb; 33(2):279-86. PubMed ID: 6101930 [TBL] [Abstract][Full Text] [Related]
7. [Acrodermatitis enteropathica-like syndrome secondary to branched-chain amino acid deficiency during treatment of maple syrup urine disease]. Templier I; Reymond JL; Nguyen MA; Boujet C; Lantuejoul S; Beani JC; Leccia MT Ann Dermatol Venereol; 2006 Apr; 133(4):375-9. PubMed ID: 16733455 [TBL] [Abstract][Full Text] [Related]
8. Maple syrup urine disease: branched-chain amino acid concentrations and metabolism in cultured human lymphoblasts. Skaper SD; Molden DP; Seegmiller JE Biochem Genet; 1976 Aug; 14(7-8):527-39. PubMed ID: 985377 [TBL] [Abstract][Full Text] [Related]
10. Clearance of branched chain amino acids by peritoneal dialysis in maple syrup urine disease. McMahon Y; MacDonnell RC Adv Perit Dial; 1990; 6():31-4. PubMed ID: 1982835 [TBL] [Abstract][Full Text] [Related]
11. Clinical consequences of disorders in the intermediate metabolism of branched chain amino acids (valine, leucine and isoleucine). Mogoş T; Cheţa CP; Mincu IT Rom J Intern Med; 1994; 32(1):57-61. PubMed ID: 8081313 [TBL] [Abstract][Full Text] [Related]
12. Acute illness in maple syrup urine disease: dynamics of protein metabolism and implications for management. Thompson GN; Francis DE; Halliday D J Pediatr; 1991 Jul; 119(1 Pt 1):35-41. PubMed ID: 2066856 [TBL] [Abstract][Full Text] [Related]
13. MAPLE SYRUP URINE DISEASE. VOYCE MA; MONTGOMERY JN; LYNCH GA; BOWMAN JK Br Med J; 1964 May; 1(5393):1293. PubMed ID: 14123637 [No Abstract] [Full Text] [Related]
14. Combined nutritional support and continuous extracorporeal removal therapy in the severe acute phase of maple syrup urine disease. Jouvet P; Jugie M; Rabier D; Desgrès J; Hubert P; Saudubray JM; Man NK Intensive Care Med; 2001 Nov; 27(11):1798-806. PubMed ID: 11810125 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of branched-chain amino acid intake in children with maple syrup urine disease and methylmalonic aciduria. Parsons HG; Carter RJ; Unrath M; Snyder FF J Inherit Metab Dis; 1990; 13(2):125-36. PubMed ID: 2116544 [TBL] [Abstract][Full Text] [Related]
16. The relationship between the branched chain amino acids and their alpha-ketoacids in maple syrup urine disease. Snyderman SE; Goldstein F; Sansaricq C; Norton PM Pediatr Res; 1984 Sep; 18(9):851-3. PubMed ID: 6483508 [TBL] [Abstract][Full Text] [Related]
17. [CLINICAL, BIOCHEMICAL, AND NEUROPATHOLOGIC ASPECTS OF MAPLE SYRUP URINE DISEASE. A KETOACIDURIA OF THE OPEN CHAIN AMINOACIDS LEUCINE, ISOLEUCINE AND VALINE]. SILBERMANSCHWARTZMAN J An Fac Med Lima; 1963 Sep; 46():339-65. PubMed ID: 14122039 [No Abstract] [Full Text] [Related]
18. Functional differences in the catabolism of branched-chain L-amino acids in cultured normal and maple syrup urine disease fibroblasts. Schadewaldt P; Wendel U Biochem Med Metab Biol; 1989 Apr; 41(2):105-16. PubMed ID: 2719855 [TBL] [Abstract][Full Text] [Related]